Literature DB >> 17017828

Realistic expectations and a disease management model for depressed patients with persistent symptoms.

Gabor I Keitner1, Christine E Ryan, David A Solomon.   

Abstract

OBJECTIVE: To describe the efficacy of currently available treatments for depression in achieving remission and to highlight additional strategies for those patients who continue to experience persistent depressive symptoms in spite of optimal treatment. DATA SOURCES: The authors reviewed the literature (electronic and hand searches) on the efficacy of current pharmacologic and psychotherapeutic antidepressant treatments and the utility of a chronic disease management model. A search of PubMed was conducted for English-language articles published from 1980 to 2005 using the keywords depression treatments, outcome, course of illness, and treatment resistant depression. DATA SYNTHESIS: Current treatments for depression leave a significant minority (20%-40%) of patients with persistent depressive symptoms. A disease management model that may be useful for major depressive disorder is described.
CONCLUSIONS: The goal of treating depression to achieve remission, although ideal, is currently unattainable for many patients. The long-term care of patients with persisting depressive symptoms may be well served by adding a disease management component to the overall treatment strategy. Doing so may help to improve coping, interpersonal functioning, and quality of life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017828     DOI: 10.4088/jcp.v67n0912

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

1.  The factor structure of lifetime depressive spectrum in patients with unipolar depression.

Authors:  G B Cassano; A Benvenuti; M Miniati; S Calugi; M Mula; L Maggi; P Rucci; A Fagiolini; F Perris; E Frank
Journal:  J Affect Disord       Date:  2008-10-22       Impact factor: 4.839

Review 2.  Zinc in the central nervous system: From molecules to behavior.

Authors:  Shannon D Gower-Winter; Cathy W Levenson
Journal:  Biofactors       Date:  2012-03-31       Impact factor: 6.113

3.  A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression.

Authors:  Gabor I Keitner; Steven J Garlow; Christine E Ryan; Philip T Ninan; David A Solomon; Charles B Nemeroff; Martin B Keller
Journal:  J Psychiatr Res       Date:  2008-06-30       Impact factor: 4.791

4.  Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression.

Authors:  Antonella Benvenuti; Paola Rucci; Simona Calugi; Giovanni B Cassano; Mario Miniati; Ellen Frank
Journal:  Int Clin Psychopharmacol       Date:  2010-03       Impact factor: 1.659

Review 5.  Effect of Exercise on Major Depressive Disorder and Schizophrenia: A BDNF Focused Approach.

Authors:  Evrim Gökçe; Emel Güneş; Erhan Nalçaci
Journal:  Noro Psikiyatr Ars       Date:  2019-10-15       Impact factor: 1.339

6.  Effectiveness of cognitive behavioral group therapy for depression in routine practice.

Authors:  Jens C Thimm; Liss Antonsen
Journal:  BMC Psychiatry       Date:  2014-10-21       Impact factor: 3.630

7.  Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012.

Authors:  Yu-Xi Wang; Yu-Tao Xiang; Yun-Ai Su; Qian Li; Liang Shu; Chee H Ng; Gabor S Ungvari; Helen Fk Chiu; Yu-Ping Nin; Gao-Hua Wang; Pei-Shen Bai; Tao Li; Li-Zhong Sun; Jian-Guo Shi; Xian-Sheng Chen; Qi-Yi Mei; Ke-Qing Li; Xin Yu; Tian-Mei Si
Journal:  Chin Med J (Engl)       Date:  2015-07-20       Impact factor: 2.628

8.  Helpful self-management strategies to cope with enduring depression from the patients' point of view: a concept map study.

Authors:  Rosa A van Grieken; Anneloes C E Kirkenier; Maarten W J Koeter; Aart H Schene
Journal:  BMC Psychiatry       Date:  2014-12-13       Impact factor: 3.630

9.  Effectiveness and cost-effectiveness of a self-management training for patients with chronic and treatment resistant anxiety or depressive disorders: design of a multicenter randomized controlled trial.

Authors:  Maringa H H Zoun; Bauke Koekkoek; Henny Sinnema; Anna D T Muntingh; Anton J L M van Balkom; Aart H Schene; Filip Smit; Jan Spijker
Journal:  BMC Psychiatry       Date:  2016-07-07       Impact factor: 3.630

10.  Tablet-based support for older adults with severe mood disorders treated in an ambulatory geriatric psychiatry setting: Protocol of a feasibility study of the eCare@Home platform.

Authors:  Josien Schuurmans; Juliette L van der Linden; Wouter van Ballegooijen; Jeroen Ruwaard; Max L Stek; Jan H Smit; Heleen Riper
Journal:  Internet Interv       Date:  2016-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.